Suchergebnisse - "MUC1 protein, human"

PubPharm (106)

1

Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing

enthalten in: Life science alliance | 2024

von Peng, W. | Giesbers, K. | Šiborová, M. | +7

2

GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors : Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies

enthalten in: International journal of molecular sciences | 2024

von Gellert, J. | Jäkel, A. | Danielczyk, A. | +6

3

MUC1 : An emerging target in cancer treatment and diagnosis

enthalten in: Bulletin du cancer | 2022

von Qing, L. | Li, Q. | Dong, Z.

4

Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo

enthalten in: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology | 2022

von Zhang, L. | Hou, Y. | Li, C. | +2

5

Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma

enthalten in: Cells | 2022

von Hull, A. | Li, Y. | Bartholomeusz, D. | +5

6

The role of epithelial membrane antigen (EMA) overexpression in the prognosis of prostatic adenocarcinoma

enthalten in: Journal of medicine and life | 2022

von Ghalib, R. | Falah, A.

7

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors

enthalten in: ESMO open | 2022

von Ochsenreither, S. | Fiedler, W. | Conte, G. | +14

ErratumIn: ESMO Open. 2022 Aug;7(4):100549. - PMID 35841804

8

MUC1 antibody-based therapeutics : the promise of cancer immunotherapy

enthalten in: Immunotherapy | 2020

von Pourjafar, M. | Samadi, P. | Saidijam, M.

9

An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities

enthalten in: Molecular cancer therapeutics | 2020

von Nicolazzi, C. | Caron, A. | Tellier, A. | +11

10

In vivo anti-MUC1+ tumor activity and sequences of high-affinity anti-MUC1-SEA antibodies

enthalten in: Cancer immunology, immunotherapy : CII | 2020

von Pichinuk, E. | Chalik, M. | Benhar, I. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]